Stay updated on Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Sign up to get notified when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.

Latest updates to the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedFallopian tube cancer is now listed as a condition on the page, and the page revision updated to v3.4.2 (replacing v3.4.1).SummaryDifference0.1%

- Check19 days agoChange DetectedAdded 'Primary peritoneal carcinoma' to the conditions/terms and introduced a resources entry for the Genetic and Rare Diseases Information Center. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check20 days agoChange DetectedSite revision updated from v3.4.0 to v3.4.1. This appears to be a behind-the-scenes update with no visible changes to the study details or page content.SummaryDifference0.0%

- Check27 days agoChange DetectedUI changes include a Show glossary toggle and updates to metadata labels (Last Update Submitted that Met QC Criteria; Revision: v3.4.0) with capitalization adjustments and No FEAR Act Data text; older capitalization variants appear to have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedFooter revision tag changed from v3.3.3 to v3.3.4. This is a minor site maintenance update.SummaryDifference0.0%

- Check62 days agoChange DetectedExpanded the study locations to include multiple sites across the United States and internationally (e.g., Victoria, Sherbrooke). Updated the revision tag to v3.3.3.SummaryDifference2%

Stay in the know with updates to Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.